{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T07:43:22Z","timestamp":1769586202814,"version":"3.49.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4230,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,2]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>The best treatment policy for some patients with hepatocellular carcinoma (HCC) and compensated cirrhosis is still controversial. The aim of this study was to evaluate the long-term survival and related prognostic factors of patients with early and intermediate HCC (Liver Unit of Barcelona classification) treated in a radiologic referral center by a multimodal image-guided tailored therapy (MIGTT), applied over time, choosing the procedure patient by patient according to the presentation of the disease. Between May 1996 and May 2003, 374 patients (210 with early and 164 with intermediate HCC) were treated with MIGTT. Radiofrequency ablation was considered the first choice; ethanol injection was preferred for nodules at risk for radiofrequency; and selective chemoembolization was preferred for nodules not recognizable at ultrasound examination, those not retreatable after an unsuccessful ablation technique, or for satellites. The rate of perioperative mortality and major complications was 0.2% and 4.5%, respectively. The 1-, 3-, and 5-year survival rates were 90%, 69%, and 49% and 83%, 43%, and 28% for patients with early and intermediate HCC, respectively. At the univariate analysis, the indicators of a poor prognosis were Child\u2019s class B, portal hypertension, abnormal bilirubin, infiltrating tumor, and abnormal serum alpha-fetoprotein (AFP) level. In conclusion, within the limits of historical comparisons, in early HCC, MIGTT should be considered an appropriate option for unresectable patients or for resectable patients presenting with adverse prognostic factors. In intermediate HCC, the 3-year survival rate obtained with MIGTT was better than the best survival rate reported with conventional chemoembolization; however, the benefit for patients presenting with poor prognostic factors remains unclear. (Liver Transpl 2004;10:S98-S106.)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.20053","type":"journal-article","created":{"date-parts":[[2004,1,31]],"date-time":"2004-01-31T00:01:29Z","timestamp":1075507289000},"page":"S98-S106","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":73,"title":["Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: Long-term survival in the experience of a single radiologic referral center"],"prefix":"10.1097","volume":"10","author":[{"given":"Tito","family":"Livraghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franca","family":"Meloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Vettori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20250326","doi-asserted-by":"crossref","first-page":"153156","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: GLOBOCAN 2000.","volume":"94","author":"Parkin","year":"2001","journal-title":"Int J Cancer"},{"key":"R2-19-20250326","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1007\/s10534-002-0808-6","article-title":"IHPBA concordant classification of primary liver cancer: working group report.","volume":"10","author":"Makuuchi","year":"2003","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"R3-19-20250326","first-page":"751755","article-title":"A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients.","volume":"28","year":"1998","journal-title":"Hepatology"},{"key":"R4-19-20250326","doi-asserted-by":"crossref","first-page":"133141","DOI":"10.1016\/S0168-8278(99)80173-1","article-title":"A new prognostic classification for predicting survival in patients with hepatocellular carcinoma.","volume":"31","author":"Chevret","year":"1999","journal-title":"J Hepatol"},{"key":"R5-19-20250326","doi-asserted-by":"crossref","first-page":"329338","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification.","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"R6-19-20250326","doi-asserted-by":"crossref","first-page":"421430","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference.","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"R7-19-20250326","doi-asserted-by":"crossref","first-page":"519524","DOI":"10.1053\/jhep.2002.32089","article-title":"Prognostic prediction and treatment strategy in hepatocellular carcinoma.","volume":"35","author":"Bruix","year":"2002","journal-title":"Hepatology"},{"key":"R8-19-20250326","doi-asserted-by":"crossref","first-page":"655661","DOI":"10.1148\/radiology.210.3.r99fe40655","article-title":"Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection.","volume":"210","author":"Livraghi","year":"1999","journal-title":"Radiology"},{"key":"R9-19-20250326","doi-asserted-by":"crossref","first-page":"322326","DOI":"10.1093\/jjco\/hye063","article-title":"Radio-frequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study.","volume":"31","author":"Ikeda","year":"2001","journal-title":"Jpn J Clin Oncol"},{"key":"R10-19-20250326","doi-asserted-by":"crossref","first-page":"235240","DOI":"10.1148\/radiol.2281020718","article-title":"Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection.","volume":"228","author":"Lencioni","year":"2003","journal-title":"Radiology"},{"key":"R11-19-20250326","doi-asserted-by":"crossref","first-page":"761768","DOI":"10.1148\/radiology.214.3.r00mr02761","article-title":"Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.","volume":"214","author":"Livraghi","year":"2000","journal-title":"Radiology"},{"key":"R12-19-20250326","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<48::AID-CNCR7>3.0.CO;2-A","article-title":"Long term results of single session PEI in patients with large hepatocellular carcinoma.","volume":"83","author":"Livraghi","year":"1998","journal-title":"Cancer"},{"issue":"P","key":"R13-19-20250326","first-page":"787","article-title":"Comparison between RF ablation and TACE in the treatment of multifocal hepatocellular carcinoma: preliminary experience.","volume":"217","author":"Livraghi","year":"2000","journal-title":"Radiology"},{"key":"R14-19-20250326","doi-asserted-by":"crossref","first-page":"441451","DOI":"10.1148\/radiol.2262012198","article-title":"Percutaneous radio-frequency ablation: complications encountered in a multicenter study of the treatment of focal liver tumors.","volume":"226","author":"Livraghi","year":"2003","journal-title":"Radiology"},{"key":"R15-19-20250326","doi-asserted-by":"crossref","first-page":"S84S88","DOI":"10.1007\/BF00686674","article-title":"Subsegmental transcatheter arterial embolization for small hepatocellular carcinoma: local therapeutic effect and 5-year survival rate.","volume":"33","author":"Matsui","year":"1994","journal-title":"Cancer Chemother Pharmacol"},{"key":"R16-19-20250326","doi-asserted-by":"crossref","first-page":"404409","DOI":"10.1007\/s005340100001","article-title":"Recurrence of hepatocellular carcinoma: multicentric occurrence or intrahepatic metastases? A viewpoint in terms of pathology.","volume":"8","author":"Nakashima","year":"2001","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"R17-19-20250326","doi-asserted-by":"crossref","first-page":"397403","DOI":"10.1007\/s005340100000","article-title":"Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience.","volume":"8","author":"Arii","year":"2001","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"R18-19-20250326","doi-asserted-by":"crossref","first-page":"522526","DOI":"10.1016\/0168-8278(95)80445-5","article-title":"No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis.","volume":"22","author":"Livraghi","year":"1995","journal-title":"J Hepatol"},{"key":"R19-19-20250326","doi-asserted-by":"crossref","first-page":"251257","DOI":"10.1093\/jjco\/27.4.251","article-title":"Therapeutic results of resection, transcatheter arterial embolization and ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study.","volume":"27","author":"Ryu","year":"1997","journal-title":"Jpn J Clin Oncol"},{"key":"R20-19-20250326","doi-asserted-by":"crossref","first-page":"707713","DOI":"10.1053\/jhep.2001.27950","article-title":"Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after ethanol injection and surgical resection.","volume":"34","author":"Yamamoto","year":"2001","journal-title":"Hepatology"},{"key":"R21-19-20250326","doi-asserted-by":"crossref","first-page":"14341440","DOI":"10.1002\/hep.510300629","article-title":"Intention to treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.","volume":"30","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"key":"R22-19-20250326","doi-asserted-by":"crossref","first-page":"722730","DOI":"10.1097\/00000658-200205000-00015","article-title":"Preoperative predictors of survival after resection of small hepatocellular carcinoma.","volume":"235","author":"Wayne","year":"2002","journal-title":"Ann Surg"},{"key":"R23-19-20250326","first-page":"3640","article-title":"Remodeling the surgical approach to hepatocellular carcinoma.","volume":"49","author":"Makuuchi","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"R24-19-20250326","doi-asserted-by":"crossref","first-page":"233238","DOI":"10.1053\/jhep.2000.9603","article-title":"Natural history of inoperable hepatocellular carcinoma: estrogen receptors status in the tumor is the strongest prognostic factor for survival.","volume":"32","author":"Villa","year":"2000","journal-title":"Hepatology"},{"key":"R25-19-20250326","doi-asserted-by":"crossref","first-page":"17341738","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"R26-19-20250326","doi-asserted-by":"crossref","first-page":"11641171","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.20053","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200402002-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T08:03:23Z","timestamp":1743235403000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200402002-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":26,"journal-issue":{"issue":"Supplement 2","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.20053","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}